X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Clinical Trials News - 09/Sep 20:09

First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma

HOUSTON, Sept. 9, 2024. Moleculin Biotech, Inc., ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced the enrollment and...

Articles similaires

Sorry! Image not available at this time

Regenxbio reports positive results from phase I/II/III CAMPSIITE trial of RGX─121 to treat patients with Hunter syndrome

pharmabiz.com - 04/Sep 00:00

Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...

Sorry! Image not available at this time

Regenxbio reports positive results from phase I/II/III CAMPSIITE trial of RGX─121 to treat patients with Hunter syndrome

pharmabiz.com - 04/Sep 00:00

Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...

Sorry! Image not available at this time

First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome

drugs.com - 05/Sep 04:09

NEW YORK, Sept. 4, 2024. Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

Sorry! Image not available at this time

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

news.medical.net - 13/Sep 16:35

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination...

Sorry! Image not available at this time

Bharat Biotech, Alopexx Inc of US to co-develop, commercialise anti-microbial vax AV0328

times of india - 11/Sep 09:13

Bharat Biotech has teamed up with Alopexx Inc to co-develop and market the broad-spectrum antimicrobial vaccine AV0328 in India and other low-income...

Sorry! Image not available at this time

Bharat Biotech, Alopexx Inc of US to co-develop, commercialise anti-microbial vax AV0328

times of india - 11/Sep 09:13

Bharat Biotech has teamed up with Alopexx Inc to co-develop and market the broad-spectrum antimicrobial vaccine AV0328 in India and other low-income...

Sorry! Image not available at this time

Cytovation to present safety and efficacy data from CICILIA phase I/IIa clinical trial evaluating CY─101 in solid tumors

pharmabiz.com - 01:13

Cytovation ASA, a clinical stage oncology company focused on the development of its first─in─class bifunctional immunotherapy CY─101 (CyPep─1)...

Sorry! Image not available at this time

RANZCR: AI used for treatment must have doctor oversight

oncologynews.com.au - 12/Sep 13:29

Artificial intelligence (AI) comes with risks as well as benefits, but must have specialist doctor oversight when treating patients, says the Royal...

Sorry! Image not available at this time

RANZCR: AI used for treatment must have doctor oversight

oncologynews.com.au - 12/Sep 13:29

Artificial intelligence (AI) comes with risks as well as benefits, but must have specialist doctor oversight when treating patients, says the Royal...

Sorry! Image not available at this time

Research offers new hope for glioblastoma treatment

sloveniatimes.com - 04/Sep 09:30

Researchers at the National Institute of Biology are exploring new avenues for more effective treatment of glioblastoma, the most aggressive form of...

Les derniers communiqués